237 related articles for article (PubMed ID: 23970467)
21. Topical steroid and non-steroidal anti-inflammatory drugs inhibit inflammatory cytokine expression on the ocular surface in the botulinum toxin B-induced murine dry eye model.
Zhu L; Zhang C; Chuck RS
Mol Vis; 2012; 18():1803-12. PubMed ID: 22815633
[TBL] [Abstract][Full Text] [Related]
22. Topical TSG-6 Administration Protects the Ocular Surface in Two Mouse Models of Inflammation-Related Dry Eye.
Lee MJ; Kim DH; Ryu JS; Ko AY; Ko JH; Kim MK; Wee WR; Khwarg SI; Oh JY
Invest Ophthalmol Vis Sci; 2015 Aug; 56(9):5175-81. PubMed ID: 26244293
[TBL] [Abstract][Full Text] [Related]
23. Modulation of integrin alpha4beta1 (VLA-4) in dry eye disease.
Ecoiffier T; El Annan J; Rashid S; Schaumberg D; Dana R
Arch Ophthalmol; 2008 Dec; 126(12):1695-9. PubMed ID: 19064851
[TBL] [Abstract][Full Text] [Related]
24. Effects of eye drops containing a mixture of omega-3 essential fatty acids and hyaluronic acid on the ocular surface in desiccating stress-induced murine dry eye.
Li Z; Choi JH; Oh HJ; Park SH; Lee JB; Yoon KC
Curr Eye Res; 2014 Sep; 39(9):871-8. PubMed ID: 24559509
[TBL] [Abstract][Full Text] [Related]
25. Topical Application of Mizoribine Suppresses CD4+ T-cell-Mediated Pathogenesis in Murine Dry Eye.
Zhang X; Lin X; Liu Z; Wu Y; Yang Y; Ouyang W; Li W; Liu Z
Invest Ophthalmol Vis Sci; 2017 Dec; 58(14):6056-6064. PubMed ID: 29204644
[TBL] [Abstract][Full Text] [Related]
26. Effect of chitosan-N-acetylcysteine conjugate in a mouse model of botulinum toxin B-induced dry eye.
Hongyok T; Chae JJ; Shin YJ; Na D; Li L; Chuck RS
Arch Ophthalmol; 2009 Apr; 127(4):525-32. PubMed ID: 19365035
[TBL] [Abstract][Full Text] [Related]
27. Neutralization of ocular surface TNF-α reduces ocular surface and lacrimal gland inflammation induced by in vivo dry eye.
Ji YW; Byun YJ; Choi W; Jeong E; Kim JS; Noh H; Kim ES; Song YJ; Park SK; Lee HK
Invest Ophthalmol Vis Sci; 2013 Nov; 54(12):7557-66. PubMed ID: 24052636
[TBL] [Abstract][Full Text] [Related]
28. Topical omega-3 and omega-6 fatty acids for treatment of dry eye.
Rashid S; Jin Y; Ecoiffier T; Barabino S; Schaumberg DA; Dana MR
Arch Ophthalmol; 2008 Feb; 126(2):219-25. PubMed ID: 18268213
[TBL] [Abstract][Full Text] [Related]
29. Experimental dry eye stimulates production of inflammatory cytokines and MMP-9 and activates MAPK signaling pathways on the ocular surface.
Luo L; Li DQ; Doshi A; Farley W; Corrales RM; Pflugfelder SC
Invest Ophthalmol Vis Sci; 2004 Dec; 45(12):4293-301. PubMed ID: 15557435
[TBL] [Abstract][Full Text] [Related]
30. Effects of osmoprotectants on hyperosmolar stress in cultured human corneal epithelial cells.
Corrales RM; Luo L; Chang EY; Pflugfelder SC
Cornea; 2008 Jun; 27(5):574-9. PubMed ID: 18520508
[TBL] [Abstract][Full Text] [Related]
31. Therapeutic Effects of STAT3 Inhibition on Experimental Murine Dry Eye.
Qu M; Qi X; Wang Q; Wan L; Li J; Li W; Li Y; Zhou Q
Invest Ophthalmol Vis Sci; 2019 Sep; 60(12):3776-3785. PubMed ID: 31503282
[TBL] [Abstract][Full Text] [Related]
32. Safety and efficacy of topical infliximab in a mouse model of ocular surface scarring.
Ferrari G; Bignami F; Giacomini C; Franchini S; Rama P
Invest Ophthalmol Vis Sci; 2013 Mar; 54(3):1680-8. PubMed ID: 23404121
[TBL] [Abstract][Full Text] [Related]
33. Improvement of corneal barrier function by the P2Y(2) agonist INS365 in a rat dry eye model.
Fujihara T; Murakami T; Fujita H; Nakamura M; Nakata K
Invest Ophthalmol Vis Sci; 2001 Jan; 42(1):96-100. PubMed ID: 11133853
[TBL] [Abstract][Full Text] [Related]
34. Dry eye-induced CCR7+CD11b+ cell lymph node homing is induced by COX-2 activities.
Ji YW; Seo Y; Choi W; Yeo A; Noh H; Kim EK; Lee HK
Invest Ophthalmol Vis Sci; 2014 Sep; 55(10):6829-38. PubMed ID: 25257053
[TBL] [Abstract][Full Text] [Related]
35. Lacrimal gland inflammatory cytokine gene expression in the botulinum toxin B-induced murine dry eye model.
Park CY; Zhuang W; Lekhanont K; Zhang C; Cano M; Lee WS; Gehlbach PL; Chuck RS
Mol Vis; 2007 Nov; 13():2222-32. PubMed ID: 18087241
[TBL] [Abstract][Full Text] [Related]
36. A mouse dry eye model induced by topical administration of the air pollutant particulate matter 10.
Li J; Tan G; Ding X; Wang Y; Wu A; Yang Q; Ye L; Shao Y
Biomed Pharmacother; 2017 Dec; 96():524-534. PubMed ID: 29032336
[TBL] [Abstract][Full Text] [Related]
37. Corticosteroid and doxycycline suppress MMP-9 and inflammatory cytokine expression, MAPK activation in the corneal epithelium in experimental dry eye.
De Paiva CS; Corrales RM; Villarreal AL; Farley WJ; Li DQ; Stern ME; Pflugfelder SC
Exp Eye Res; 2006 Sep; 83(3):526-35. PubMed ID: 16643899
[TBL] [Abstract][Full Text] [Related]
38. Topical Delivery of Levocarnitine to the Cornea and Anterior Eye by Thermosensitive in-situ Gel for Dry Eye Disease.
Ma B; Pang L; Huang P; Bai J; Zhang Z; Wu H; Cai M; Yang J; Xu Y; Yin X; Qu C; Ni J
Drug Des Devel Ther; 2021; 15():2357-2373. PubMed ID: 34121838
[TBL] [Abstract][Full Text] [Related]
39. Improvement of Outcome Measures of Dry Eye by a Novel Integrin Antagonist in the Murine Desiccating Stress Model.
Krauss AH; Corrales RM; Pelegrino FS; Tukler-Henriksson J; Pflugfelder SC; de Paiva CS
Invest Ophthalmol Vis Sci; 2015 Sep; 56(10):5888-95. PubMed ID: 26348638
[TBL] [Abstract][Full Text] [Related]
40. Investigation of corneal effect of different types of artificial tears in a simulated dry eye condition using a novel porcine dry eye model (pDEM).
Choy EP; Cho P; Benzie IF; Choy CK
Cornea; 2006 Dec; 25(10):1200-4. PubMed ID: 17172898
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
